- Home
- HUMA vs ABSI Comparison
HUMA vs ABSI Comparison
Compare HUMA & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- ABSI
- Stock Information
- Founded
- HUMA 2004
- ABSI 2011
- Country
- HUMA United States
- ABSI United States
- Employees
- HUMA N/A
- ABSI N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- HUMA Health Care
- ABSI Health Care
- Exchange
- HUMA Nasdaq
- ABSI Nasdaq
- Market Cap
- HUMA 250.2M
- ABSI 338.0M
- IPO Year
- HUMA N/A
- ABSI 2021
- Fundamental
- Price
- HUMA $1.51
- ABSI $2.39
- Analyst Decision
- HUMA Strong Buy
- ABSI Strong Buy
- Analyst Count
- HUMA 8
- ABSI 5
- Target Price
- HUMA $10.88
- ABSI $7.98
- AVG Volume (30 Days)
- HUMA 5.9M
- ABSI 4.4M
- Earning Date
- HUMA 08-11-2025
- ABSI 08-12-2025
- Dividend Yield
- HUMA N/A
- ABSI N/A
- EPS Growth
- HUMA N/A
- ABSI N/A
- EPS
- HUMA N/A
- ABSI N/A
- Revenue
- HUMA $818,000.00
- ABSI $4,138,000.00
- Revenue This Year
- HUMA N/A
- ABSI $44.71
- Revenue Next Year
- HUMA $949.92
- ABSI $374.26
- P/E Ratio
- HUMA N/A
- ABSI N/A
- Revenue Growth
- HUMA N/A
- ABSI 27.32
- 52 Week Low
- HUMA $1.15
- ABSI $2.01
- 52 Week High
- HUMA $6.77
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- HUMA 36.87
- ABSI 33.33
- Support Level
- HUMA $1.43
- ABSI $2.50
- Resistance Level
- HUMA $1.67
- ABSI $2.73
- Average True Range (ATR)
- HUMA 0.15
- ABSI 0.18
- MACD
- HUMA -0.01
- ABSI -0.04
- Stochastic Oscillator
- HUMA 23.32
- ABSI 1.94
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.